Tudor Investment Corp’s Caribou Biosciences CRBU Stock Holding History

Tudor Investment Corp’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-30,073	Closed	-$58.9K	–	3089
2024 Q3	$58.9K	Buy	+30,073	New	+$61.6K	﹤0.01%	2616
2024 Q2	–	Sell	-29,583	Closed	-$152K	–	2384
2024 Q1	$152K	Buy	+29,583	New	+$182K	﹤0.01%	2070
2023 Q1	–	Sell	-29,997	Closed	-$188K	–	2496
2022 Q4	$188K	Buy	+29,997	New	+$267K	﹤0.01%	2142
2022 Q3	–	Sell	-35,216	Closed	-$191K	–	2358
2022 Q2	$191K	Buy	35,216 +1,476	+4%	+$11.3K	0.01%	1836
2022 Q1	$310K	Buy	33,740 +3,719	+12%	+$39.2K	0.01%	1536
2021 Q4	$453K	Buy	+30,021	New	+$584K	0.01%	1548

Other funds holding CRBU

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

EWM

Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tudor Investment Corp's CRBU Position: Q4 2024 in Review

Tudor Investment Corp sold out of Caribou Biosciences (CRBU) in Q4 2024, closing a stake of 30,073 shares — an estimated $58.9K sold.

Tudor Investment Corp first reported a position in CRBU in Q4 2021 and held it in 6 quarters. The position peaked at $453K in Q4 2021. 133 funds tracked by Wall St. Rank hold CRBU as of Q4 2024.

Tudor Investment Corp reported no remaining Caribou Biosciences position as of Q4 2024 after selling out during the quarter.
Tudor Investment Corp sold 30,073 Caribou Biosciences shares in Q4 2024, an estimated $58.9K.
Tudor Investment Corp first reported a position in Caribou Biosciences in Q4 2021 and held it in 6 quarters.
Tudor Investment Corp's Caribou Biosciences position peaked at $453K in Q4 2021.
133 funds tracked by Wall St. Rank held Caribou Biosciences as of Q4 2024.

Based on Tudor Investment Corp's 13F filing for Q4 2024, filed 14 Feb 2025.